T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial

被引：13
|
作者：
Blixt, Lisa [1 ,2 ]
Wullimann, David [3 ]
Aleman, Soo [4 ,5 ]
Lundin, Jeanette [2 ]
Chen, Puran [3 ]
Gao, Yu [3 ]
Cuapio, Angelica [3 ]
Akber, Mira [3 ]
Lange, Joshua [3 ]
Rivera-Ballesteros, Olga [3 ]
Buggert, Marcus [3 ]
Ljunggren, Hans-Gustaf [3 ]
Hansson, Lotta [1 ,2 ]
Osterborg, Anders [1 ,2 ]
机构：
[1] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden
[2] Karolinska Inst, Deptartment Oncol Pathol, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[5] Karolinska Inst, Dept Med Huddinge, Infect Dis, Stockholm, Sweden
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 04期
基金：
瑞典研究理事会;
关键词：
D O I：
10.3324/haematol.2021.280300
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1000 / 1003
页数：4
相关论文
共 50 条
  • [1] Diminished T-cell immune responses to SARS-CoV-2 omicron variant after BNT162b2 vaccination
    Jordan, Stanley C.
    Shin, Bong-Ha
    Rodriguez, Edgar
    Vo, Ashley
    Ammerman, Noriko
    Zhang, Ruan
    IMMUNOLOGY LETTERS, 2022, 248 : 123 - 125
  • [2] Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
    Bergman, Peter
    Blennow, Ola
    Hansson, Lotta
    Mielke, Stephan
    Nowak, Piotr
    Chen, Puran
    Soderdahl, Gunnar
    Osterborg, Anders
    Smith, C. I. Edvard
    Wullimann, David
    Vesterbacka, Jan
    Lindgren, Gustaf
    Blixt, Lisa
    Friman, Gustav
    Wahren-Borgstrom, Emilie
    Nordlander, Anna
    Gomez, Angelica Cuapio
    Akber, Mira
    Valentini, Davide
    Norlin, Anna-Carin
    Thalme, Anders
    Bogdanovic, Gordana
    Muschiol, Sandra
    Nilsson, Peter
    Hober, Sophia
    Lore, Karin
    Chen, Margaret Sallberg
    Buggert, Marcus
    Ljunggren, Hans-Gustaf
    Ljungman, Per
    Aleman, Soo
    EBIOMEDICINE, 2021, 74
  • [3] Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia
    da Cunha-Bang, Caspar
    Kirkby, Nikolai S.
    Friis-Hansen, Lennart
    Niemann, Carsten U.
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 503 - 505
  • [4] T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
    Sophonmanee, Ratchanon
    Ongarj, Jomkwan
    Seeyankem, Bunya
    Seepathomnarong, Purilap
    Intapiboon, Porntip
    Surasombatpattana, Smonrapat
    Uppanisakorn, Supattra
    Sangsupawanich, Pasuree
    Chusri, Sarunyou
    Pinpathomrat, Nawamin
    VACCINES, 2022, 10 (09)
  • [5] SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies
    Terpos, Evangelos
    Fotiou, Despina
    Karalis, Vangelis
    Ntanasis-Stathopoulos, Ioannis
    Sklirou, Aimilia D.
    Gavriatopoulou, Maria
    Malandrakis, Panagiotis
    Iconomidou, Vassiliki A.
    Kastritis, Efstathios
    Trougakos, Ioannis P.
    Dimopoulos, Meletios A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (10) : 1300 - 1308
  • [6] A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
    Dickey, John B.
    Albert, Elisabeth
    Badr, Mai
    Laraja, Kristin M.
    Sena, Laureen M.
    Gerson, David S.
    Saucedo, Jason E.
    Qureshi, Waqas
    Aurigemma, Gerard P.
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (09) : 1862 - 1863
  • [7] Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
    Appelman, Brent
    van der Straten, Karlijn
    Lavell, A. H. Ayesha
    Schinkel, Michiel
    Slim, Marleen A.
    Poniman, Meliawati
    Burger, Judith A.
    Oomen, Melissa
    Tejjani, Khadija
    Vlaar, Alexander P. J.
    Wiersinga, W. Joost
    Smulders, Yvo M.
    van Vught, Lonneke A.
    Sanders, Rogier W.
    van Gils, Marit J.
    Bomers, Marije K.
    Sikkens, Jonne J.
    EBIOMEDICINE, 2021, 72
  • [8] Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination
    Cabau, Georgiana
    Badii, Medeea
    Mirea, Andreea M.
    Gaal, Orsolya I.
    van Emst, Liesbeth
    Popp, Radu A.
    Crisan, Tania O.
    Joosten, Leo A. B.
    VACCINES, 2024, 12 (07)
  • [9] The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses
    Fohse, F. Konstantin
    Geckin, Busranur
    Overheul, Gijs J.
    van de Maat, Josephine
    Kilic, Gizem
    Bulut, Ozlem
    Hoogerwerf, Jacobien
    ten Oever, Jaap
    Simonetti, Elles
    van de Veerdonk, Frank L.
    Joosten, Leo A. B.
    Haagmans, Bart L.
    van Crevel, Reinout
    Li, Yang
    van Rij, Ronald P.
    GeurtsvanKessel, Corine
    de Jonge, Marien I.
    Dominguez-Andres, Jorge
    Netea, Mihai G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 90 - 90
  • [10] Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
    Saresella, Marina
    Piancone, Federica
    Marventano, Ivana
    Hernis, Ambra
    Trabattoni, Daria
    Invernizzi, Mattia
    La Rosa, Francesca
    Clerici, Mario
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345